Free Trial

Cogent Biosciences (COGT) News Today

Cogent Biosciences logo
$7.84 +0.04 (+0.51%)
(As of 12/20/2024 05:51 PM ET)
Cogent Biosciences, Inc. stock logo
State Street Corp Sells 605,500 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
State Street Corp cut its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 15.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,231,462 shares of the technology company
Cogent Biosciences, Inc. stock logo
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four h
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 4.4% - What's Next?
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 4.4% - Time to Sell?
Cogent Biosciences, Inc. stock logo
Cogent Biosciences, Inc. (NASDAQ:COGT) Sees Large Increase in Short Interest
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 8,420,000 shares, a growth of 9.1% from the November 15th total of 7,720,000 shares. Based on an average daily volume of 1,250,000 shares, the short-interest ratio is currently 6.7 days.
HC Wainwright Has Negative Forecast for COGT FY2024 Earnings
Cogent Biosciences, Inc. stock logo
HC Wainwright Has Negative Estimate for COGT FY2024 Earnings
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Investment analysts at HC Wainwright lowered their FY2024 earnings estimates for shares of Cogent Biosciences in a research report issued on Wednesday, December 11th. HC Wainwright analyst R. Burns now anticipates that the technology company
Cogent Biosciences, Inc. stock logo
HC Wainwright Reiterates Buy Rating for Cogent Biosciences (NASDAQ:COGT)
HC Wainwright restated a "buy" rating on shares of Cogent Biosciences in a report on Wednesday.
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Stock Rating Lowered by Needham & Company LLC
Needham & Company LLC lowered shares of Cogent Biosciences from a "buy" rating to a "hold" rating in a report on Wednesday.
Cogent Biosciences, Inc. stock logo
Charles Schwab Investment Management Inc. Has $8.92 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)
Charles Schwab Investment Management Inc. lifted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 20.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 825,793 shares of the t
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Earns "Buy" Rating from Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $15.00 target price on shares of Cogent Biosciences in a research report on Monday.
Cogent Biosciences, Inc. stock logo
Fmr LLC Has $89.85 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)
Fmr LLC increased its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 8.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,319,411 shares of the technology company's stock after purchasing an add
Cogent Biosciences, Inc. stock logo
Redmile Group LLC Sells 315,593 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
Redmile Group LLC decreased its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 6.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 4,484,380 shares of the technology company's stock after selling 315,593 shares during the
Cogent Biosciences, Inc. stock logo
Bank of Montreal Can Invests $3.14 Million in Cogent Biosciences, Inc. (NASDAQ:COGT)
Bank of Montreal Can purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 287,610 shares of the technology company
Cogent Biosciences, Inc. stock logo
HighVista Strategies LLC Has $2.44 Million Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)
HighVista Strategies LLC cut its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 19.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 225,633 shares of the technology company's stock after selling 5
Cogent Biosciences, Inc. stock logo
Cinctive Capital Management LP Buys 157,969 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
Cinctive Capital Management LP increased its stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 91.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 330,419 shares
Cogent Biosciences, Inc. stock logo
Walleye Capital LLC Makes New Investment in Cogent Biosciences, Inc. (NASDAQ:COGT)
Walleye Capital LLC bought a new stake in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 557,326 shares of the technology company's stock, valued at
Cogent Biosciences, Inc. stock logo
Eventide Asset Management LLC Sells 479,357 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
Eventide Asset Management LLC trimmed its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 34.3% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 919,635 shares of the technology company's stock aft
Cogent Biosciences, Inc. stock logo
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of "Moderate Buy" from Analysts
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and five
Cogent Biosciences, Inc. stock logo
FY2024 EPS Forecast for Cogent Biosciences Lifted by Analyst
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Research analysts at Leerink Partnrs increased their FY2024 earnings per share estimates for shares of Cogent Biosciences in a note issued to investors on Wednesday, November 13th. Leerink Partnrs analyst A. Berens now expects that the techno
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Trading Down 7% - Should You Sell?
Cogent Biosciences (NASDAQ:COGT) Trading Down 7% - Time to Sell?
Cogent Biosciences, Inc. stock logo
Equities Analysts Set Expectations for COGT FY2027 Earnings
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Stock analysts at Leerink Partnrs raised their FY2027 earnings per share (EPS) estimates for Cogent Biosciences in a report released on Wednesday, November 13th. Leerink Partnrs analyst A. Berens now expects that the technology company will e
Cogent Biosciences, Inc. stock logo
What is Lifesci Capital's Estimate for COGT FY2024 Earnings?
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Research analysts at Lifesci Capital cut their FY2024 EPS estimates for shares of Cogent Biosciences in a note issued to investors on Wednesday, November 13th. Lifesci Capital analyst S. Slutsky now anticipates that the technology company wil
Cogent Biosciences, Inc. stock logo
Wedbush Reduces Earnings Estimates for Cogent Biosciences
Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) - Analysts at Wedbush decreased their FY2024 earnings per share (EPS) estimates for shares of Cogent Biosciences in a research report issued on Tuesday, November 12th. Wedbush analyst D. Nierengarten now forecasts that the technology company wi
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Issues Earnings Results
Cogent Biosciences (NASDAQ:COGT - Get Free Report) issued its quarterly earnings results on Tuesday. The technology company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.57) by ($0.07). During the same period in the prior year, the firm earned ($0.64) EPS.
Cogent Biosciences, Inc. stock logo
Needham & Company LLC Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00
Needham & Company LLC lowered their target price on Cogent Biosciences from $16.00 to $15.00 and set a "buy" rating for the company in a research note on Wednesday.
Buy Recommendation for Cogent Biosciences Amid Unjustified Stock Decline
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Shares Down 5.3% - What's Next?
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.3% - Time to Sell?
Cogent Biosciences, Inc. stock logo
HC Wainwright Reaffirms "Buy" Rating for Cogent Biosciences (NASDAQ:COGT)
HC Wainwright restated a "buy" rating and set a $17.00 target price on shares of Cogent Biosciences in a report on Monday.
Cogent Biosciences, Inc. stock logo
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of "Moderate Buy" from Brokerages
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and five have issued a buy
Cogent Biosciences, Inc. stock logo
Hennion & Walsh Asset Management Inc. Increases Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)
Hennion & Walsh Asset Management Inc. grew its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 34.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 171,9
Cogent Biosciences, Inc. stock logo
Needham & Company LLC Reiterates Buy Rating for Cogent Biosciences (NASDAQ:COGT)
Needham & Company LLC reissued a "buy" rating and issued a $16.00 target price on shares of Cogent Biosciences in a research report on Thursday.
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Sets New 52-Week High - Here's What Happened
Cogent Biosciences (NASDAQ:COGT) Hits New 52-Week High - What's Next?
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Trading Down 2.4% - Here's Why
Cogent Biosciences (NASDAQ:COGT) Trading Down 2.4% - Should You Sell?
Cogent Biosciences, Inc. stock logo
Cogent Biosciences (NASDAQ:COGT) Shares Up 4.6% - Time to Buy?
Cogent Biosciences (NASDAQ:COGT) Trading Up 4.6% - Still a Buy?
Cogent Biosciences, Inc. stock logo
Dimensional Fund Advisors LP Sells 463,901 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)
Dimensional Fund Advisors LP trimmed its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 33.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 930,297 shares of the technology company's stock after selling 463,901 shares during the period.
Cogent Biosciences, Inc. stock logo
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven brokerages that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and five have given a
Get Cogent Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter.

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 

COGT Media Mentions By Week

COGT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

COGT
News Sentiment

-0.08

0.60

Average
Medical
News Sentiment

COGT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

COGT Articles
This Week

6

3

COGT Articles
Average Week

Get Cogent Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners